Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Acyclovir recalled?

Yes — there is an active recall. 3 ongoing FDA recalls mention Acyclovir (19 total). Check the affected lots below.

Most common reason: Particulate / foreign matter (5 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Acyclovir. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Acyclovir recalls in 2026

1 initiated in 2026, 19 in total — newest first
Class II · Moderate risk

Acyclovir Sodium Injection

Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.

Completed Particulate / foreign matter AuroMedics Pharma LLC NDC 55150-154-10 D-0013-2023
Class III · Low risk

Acyclovir Tablets

Labeling: Incorrect or Missing Lot and/or Exp Date

Terminated Labeling / mix-up Heritage Pharmaceuticals Inc NDC 23155-227-01 D-0367-2021
Class II · Moderate risk

Acyclovir Tablets

Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg

Terminated Labeling / mix-up Zydus Pharmaceuticals USA Inc NDC 68382-791-01 D-1272-2019
Class II · Moderate risk

Acyclovir Tablets

Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.

Terminated Particulate / foreign matter Apace KY LLC NDC 50268-061-11 D-0544-2018
Class II · Moderate risk

Acyclovir Sodium active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-501-2015
Class III · Low risk

Acyclovir Oral Suspension

Failed Stability Specification; product viscosity and or pH are below specification.

Terminated Stability / shelf life Hi-Tech Pharmacal Co., Inc. NDC 50383-810-16 D-389-2014
Class II · Moderate risk

Acyclovir Tablets USP 800 mg

Presence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile rubber glove embedded within the tablets.

Terminated Particulate / foreign matter Apotex Inc. NDC 60505-5307-1 D-017-2014
Class II · Moderate risk

Acyclovir

Labeling: Label Mixup: ACYCLOVIR, Tablet, 800 mg may have potentially been mislabeled as the following drug: PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, NDC 64679043304, Pedigree: AD70690_4, EXP: 5/29/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-858-2014
Class II · Moderate risk

Acyclovir

Labeling: Label Mixup: ACYCLOVIR, Capsule, 200 mg may have potentially been mislabeled as one of the following drugs: CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: AD60240_51, EXP: 5/22/2014; METOPROLOL TARTRATE, Tablet, 25 mg, NDC 57664050652, Pedigree: W002841, EXP: 6/7/2014; METOPROLOL TARTRATE, Tablet, 50 mg, NDC 00093073301, Pedigree: W003900, EXP: 6/27/2014; acetaZOLAMIDE

Terminated Labeling / mix-up Aidapak Services, LLC D-857-2014
Class II · Moderate risk

Acyclovir Ophthalmic 3% Ointment 5 Gm

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1450-2012